{"id":324036,"date":"2026-03-05T10:12:24","date_gmt":"2026-03-05T02:12:24","guid":{"rendered":"http:\/\/www.namnewsnetwork.org\/?p=324036"},"modified":"2026-03-05T10:12:24","modified_gmt":"2026-03-05T02:12:24","slug":"immunoscape-announces-memorandum-of-understanding-for-clinical-trial-with-premier-u-s-cancer-center","status":"publish","type":"post","link":"http:\/\/namnewsnetwork.org\/?p=324036","title":{"rendered":"ImmunoScape Announces Memorandum of Understanding for Clinical Trial with Premier U.S. Cancer Center"},"content":{"rendered":"\n<p><strong>SINGAPORE &amp; SAN DIEGO, March 5 (Bernama-BUSINESS WIRE) &#8212;&nbsp;<\/strong><a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.immunoscape.com%2F&amp;esheet=54437977&amp;newsitemid=20260304395544&amp;lan=en-US&amp;anchor=ImmunoScape+Pte.+Ltd.&amp;index=1&amp;md5=719bd5a8488d34cc515e2b25ebba926f\">ImmunoScape Pte. Ltd.<\/a>, an A*STAR spin-out backed by Amgen Ventures and EDBI that is developing next-generation TCR-based cancer immunotherapies, today announced the execution of a Memorandum of Understanding (MOU) with a premier NCI-designated Comprehensive Cancer Center in the United States, renowned globally for its pioneering history in cellular immunotherapy. This partnership will fast-track ImmunoScape&#8217;s \u201cSeed and Boost\u201d platform into the clinic. Concurrently, the company announced a strategic investment from Leonardo DiCaprio.<\/p>\n\n\n\n<p><strong>Accelerating the \u201cSeed and Boost\u201d Clinical Program<\/strong><\/p>\n\n\n\n<p>Under the terms of the MOU, ImmunoScape will partner with the cancer center to launch an investigator-initiated clinical trial targeting\u00a0<strong>Wilms Tumor 1 (WT1)<\/strong>\u00a0positive solid tumors. The trial will focus on four difficult-to-treat indications:\u00a0<strong>ovarian, mesothelioma, and\u00a0<\/strong>other high-unmet need solid tumors such as<strong>\u00a0pancreatic and colorectal cancers<\/strong>. The study is scheduled to dose its first patients by September 2026.<\/p>\n\n\n\n<p><a href=\"https:\/\/mrem.bernama.com\/viewsm.php?idm=53672\">https:\/\/mrem.bernama.com\/viewsm.php?idm=53672<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SINGAPORE &amp; SAN DIEGO, March 5 (Bernama-BUSINESS WIRE) &#8212;&nbsp;ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures and EDBI that is developing next-generation TCR-based cancer immunotherapies, today announced the execution of a Memorandum of Understanding (MOU) with a premier NCI-designated Comprehensive Cancer Center in the United States, renowned globally for its pioneering history in [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[315],"tags":[],"_links":{"self":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/324036"}],"collection":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=324036"}],"version-history":[{"count":1,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/324036\/revisions"}],"predecessor-version":[{"id":324037,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/324036\/revisions\/324037"}],"wp:attachment":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=324036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=324036"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=324036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}